(Q71769487)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Octreotide as first-line treatment for women with metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

main subject

metastatic breast cancer

1 reference

3

V J Suman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1

J N Ingle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

C G Kardinal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J E Krook

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A K Hatfield

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

235-237

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00210797

21 October 2019

exact match

0 references

cites work

Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: an analysis of patients entered on four prospective clinical trials

1 reference

12 December 2020

Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture

1 reference

12 December 2020

Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells

1 reference

12 December 2020

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1 reference

12 December 2020

A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic

1 reference

12 December 2020

Growth hormone regulates the abundance of insulin-like growth factor I RNA in adult rat liver.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00210797

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913847%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference